|
Therapy of B-Cell Acute Lymphoblastic Leukemia: An Evolving Landscape
Presented by Amir Fathi, MD, Associate Professor of Medicine at Harvard Medical School, this activity will highlight individualized treatment selection for patients with acute lymphoblastic leukemia (ALL), as well as recent efficacy and safety data for novel therapeutic strategies. Start the activity now.
STATEMENT OF NEED
Acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the proliferation of immature lymphoid cells throughout the bone marrow and blood (Rana... |
|
|
Improving Outcomes in Hodgkin Lymphoma
This in-depth discussion, presented by Louis Diehl, MD, Professor of Medicine at Duke University Medical School, will feature strategies for incorporating predictive and prognostic markers, recent efficacy and safety data, and adverse event management strategies into treatment selection for patients with Hodgkin lymphoma (HL). Start the activity now.
STATEMENT OF NEED
Hodgkin lymphoma (HL) is a rare malignancy of the lymph nodes and lymphatic system, with about 8,830 new cases diagnosed ... |
|
|
Updates in Myelodysplastic Syndromes: Improving Patient Outcomes
This activity, presented by Mikkael Sekeres, MD, Chief of the Division of Hematology at the University of Miami Health System, will focus on predictive and prognostic markers for myelodysplastic syndromes (MDS), emerging data on novel therapies, and strategies to optimize safety and tolerability for patients with this disease. Start the activity now.
STATEMENT OF NEED
Myelodysplastic syndromes (MDS) comprise a heterogeneous group ofmyeloid malignanciesthat derive from abnormal multipot... |
|
Implementing the APA Guidelines for the Treatment of Schizophrenia: Caring for the Whole Person
In fall 2020, the American Psychiatric Association (APA) released new practice guidelines for the treatment of patients with schizophrenia. The new guidelines were eagerly awaited, because in the 16 years since the last update, many important discoveries about schizophrenia had been made. An overarching theme in the new APA guidelines is person-centered care. This approach is critical for improving outcomes; currently, as few as 14% to 50% of patients with schizophrenia achieve recovery. Howe... |
|
|
New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia
Gain expert insight on new treatment approaches to improve outcomes for patients with immune thrombocytopenia, including individualized treatment for patients who relapse and strategies to alleviate and improve supportive care. This discussion is led by Howard Liebman, MD, Professor of Medicine and Pathology at the University of Southern California Keck School of Medicine, and Allison Miller lmahiyerobo, MSN, APN, Advanced Practice Nurse at Hematology and Oncology Physicians of Englewood. Star... |
|
Newborn Screening: From RUSP to Reality
This is the first module in a four-part curriculum focused on Best Practices for Explaining Newborn Screening Results to Parents. This module will provide clinicians with the fundamentals of newborn screening. |
|
|
Newborn Screening: Hemoglobinopathies and Newer Disorders on the RUSP
This is the fourth module in a four-part curriculum focused on Best Practices for Explaining Newborn Screening Results to Parents. This module will focus on hemoglobinopathies and newer disorders which are part of the Recommended Uniform Screening Panel (RUSP) in order to better prepare clinicians to discuss positive results with new parents. |
|
|
Newborn Screening: Metabolic Conditions
This is the third module in a four-part curriculum focused on Best Practices for Explaining Newborn Screening Results to Parents. This module will focus on metabolic diseases which are part of the Recommended Uniform Screening Panel (RUSP) in order to better prepare clinicians to discuss positive results with new parents. |
|
|
Newborn Screening: Talking to Parents
This is the second module in a four-part curriculum focused on Best Practices for Explaining Newborn Screening Results to Parents. This module will focus on how to talk to parents about positive NBS results. |
|
|
Video Viewpoint Strategy Session: Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer
This expert-led discussion, presented by Ticiana Leal, MD, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, and Beth Sandy, MSN, CRNP, Thoracic Oncology Nurse Practitioner at Abramson Cancer Center of University of Pennsylvania, will focus on emerging efficacy and safety data on immunotherapy-based strategies, supportive care plans for adverse events, and optimizing care plans for the survivorship of patients with non–small cell lung cancer. ... |
|
|
Video Viewpoint Strategy Session: New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia
Discover recent developments in the prevention, treatment, and management of chemotherapy-induced neutropenia, including a comprehensive understanding of the risk factors and current clinical practice guidelines. This activity is presented by Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, Professor, University of Washington, and Maura Abbott, PhD, AOCNP®, CPNP, Columbia University School of Nursing. Start the activity now.
STATEMENT OF NEED
Chemotherapy-induced neutropenia (CIN) is a potent... |
|
|
Podcast: New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia
Discover recent developments in the prevention, treatment, and management of chemotherapy-induced neutropenia, including a comprehensive understanding of the risk factors and current clinical practice guidelines. This activity is presented by Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, Professor, University of Washington, and Maura Abbott, PhD, AOCNP®, CPNP, Columbia University School of Nursing. Start the activity now.
STATEMENT OF NEED
Chemotherapy-induced neutropenia (CIN) is a potent... |
|
|
Video Viewpoint Strategy Session: Emerging Checkpoint Inhibitor–Based Strategies for Advanced Endometrial Cancer
Gain expert insight and enhance your clinical knowledge with this case-based activity focusing on the pathology, treatment, and management of advanced endometrial cancer, presented by leading experts Ritu Salani, MD, Director of the Division of Gynecologic Oncology and Professor of Obstetrics and Gynecology at the University of California, Los Angeles (UCLA), and Floor Backes, MD, Professor of Obstetrics and Gynecology at The Ohio State University College of Medicine. Start the activity now!
... |
|
|
Podcast: Emerging Checkpoint Inhibitor–Based Strategies for Advanced Endometrial Cancer
This expert-led episode of Oncology Data Advisor TM, presented by leading experts Ritu Salani, MD, Director of the Division of Gynecologic Oncology and Professor of Obstetrics and Gynecology at the University of California, Los Angeles (UCLA), and Floor Backes, MD, Professor of Obstetrics and Gynecology at The Ohio State University College of Medicine.ain expert insight and enhance your clinical knowledge with this case-based activity focusing on the pathology, treatment, and management of adv... |
|
Keeping Up with Advances in MS: Cases in Diagnosis and Treatment, A Case-Based Roadmap for Improved Patient Outcomes in Multiple Sclerosis
Join Edward Fox, MD, PhD, and Matthew Schindler, MD, PhD, in an interactive case-based roadmap for improved outcomes in patients with MS. In addition to addressing diagnostic challenges, Drs. Fox and Schindler share their insights into integrating advances in the pharmacologic treatment of patients with MS, focusing on the safety and efficacy of targeted therapies. |
|
|
Diagnosis and Evidence-Based Management of T-Cell Lymphoma
STATEMENT OF NEED
T-cell lymphoma (TCL) is an uncommon subtype accounting for approximately 15% of all cases of non-Hodgkin lymphoma in the United States (LRF, 2022). Compared with its B-cell counterpart, TCL has a poor prognosis and is associated with a 5-year survival rate of less than 20%. The clinical and pathologic presentations of TCL are varied and often nonspecific, making diagnosis and treatment challenging (Salem et al, 2021). In this webinar, Aaron Goodman, MD, will update clinic... |
|
|
Managing Symptom Burden and Optimizing Treatment Outcomes in Myelofibrosis
Learn more about myelofibrosis risk factors, novel therapies to slow disease progression and reduce symptoms, and strategies to maintain quality of life in this comprehensive activity presented by John Mascarenhas, MD, Professor of Medicine at Mount Sinai Icahn School of Medicine. Start the activity now!
STATEMENT OF NEED
Myelofibrosis is a rare myeloproliferative neoplasm characterized by the buildup of scar tissue in the bone marrow, leading to decreased erythropoiesis, progressive bon... |
|
|
Key Considerations in Managing Atopic Dermatitis in Black Patients
Statement of Need
Atopic dermatitis (AD), a severe form of eczema and intense pruritus, is associated with a substantial and multifaceted patient-reported burden that encompasses sleep disturbances, anxiety, depression, reduced function/productivity, and impaired quality of life. The incidence of AD is high, estimated to be approximately 15%-20% in children and 1%-3% in adults worldwide (Yong & Tay, 2017). Population studies within the United States have shown that AD disproportionately... |
|
An Illustrated Guide to Meeting the Challenges of Treating Hemophilia
In this activity, Steven Pipe, MD and Guy Young, MD introduce the unmet medical needs experienced by patients with hemophilia. They review the mechanisms of action and most recent clinical trial data for the most advanced substitution therapies (emicizumab), hemostatic rebalancing agents (concizumab, marstacimab, and fitusiran), and gene therapies. The faculty also discuss how approval of these treatments could affect patient care, and the questions that need to be addressed in ongoing phase 3... |
|
Paired Conversations: The Management of Patients With Hepatorenal Syndrome-Acute Kidney Injury: An International Perspective
This activity consists of 6 paired conversations with experts from Europe and the United States in the fields of hepatology, critical care, nephrology, and transplantation. During these paired conversations, the faculty explore revised diagnostic criteria, emerging treatment, and coordinating effective multidisciplinary care. In addition, the faculty panel collaboratively reviews a patient case where they share international perspectives on the nonpharmacological and pharmacological treatment ... |
|
|
Podcast: New Opportunities for Improved Patient Outcomes in Graft-Versus-Host-Disease
STATEMENT OF NEED
Graft-versus-host disease (GHVD) is a common complication of allogeneic hematopoietic stem cell transplant (HSCT) and a major contributor to morbidity and mortality (DeFilipp et al, 2021; Malard et al, 2020). Acute GVHD occurs within 100 days of transplant and typically targets the skin, gastrointestinal tract, and liver (LLS, 2022). Chronic GVHD often presents within the first year following HSCT but may develop in subsequent years. It most commonly affects the skin; howe... |
|
|
Overcoming Nursing Management Challenges in Metastatic Castration-Resistant Prostate Cancer
STATEMENT OF NEED
Prostate cancer is the most common tumor type affecting men in the United States. An estimated 268,490 new cases are diagnosed annually, and 34,500 people die of the disease (ACS, 2022). Typically, androgen deprivation therapy (ADT) is administered for progressive disease. However, castration resistance or unresponsiveness to ADT or antiandrogens frequently develop over time. Nonmetastatic castration-resistant prostate cancer (CRPC) is a highly heterogeneous disease proces... |
|
|
Advances in Gene Therapy for Lysosomal Diseases
This CME/CE activity highlights the current trends in gene therapy for lysosomal storage diseases as well as some of the safety concerns with such therapy.
This activity provides continuing education credit for Physicians, Physician Assistants, Nurse Practitioners, Nurses, Genetic Counselors as well as a statement of participation for other participants. |
|
|
Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer
This case-based podcast presented by i3 Health brings together two leading experts, Anne Chiang, MD, PhD, Associate Professor of Medicine, and Henry Park, MD, MPH, Chief of the Thoracic Radiotherapy Program, both at Yale School of Medicine, who will examine recent clinical advances and new opportunities in the management of SCLC and discuss key clinical questions engendered by recent advances in treatment and the need for individualized care. Start the activity now.
Statement of Need
An ... |
|
|
Cardio-Oncology Multidisciplinary Practice (COMP) 2023
Overview
This activity is for cardiology and oncology nurses, advanced practice registered nurses, pharmacists, and allied health care personnel who are involved in the management of patients with cancer and cardiovascular disease. Cardiovascular disease and cancer are the number one and two causes of death respectively in the United States. Both cardiology and oncology are rapidly evolving fields that often do not intersect in terms of their educational and training programs. With the develo... |
|
|
Navigating Advances in Alport Syndrome: Enhancing Diagnosis and Optimizing Outcomes
Target Audience
This activity is designed to meet the educational needs of nephrologists, ophthalmologists, audiologists, and allied healthcare professionals who during their practice may treat and/or manage patients with Alport syndrome.
Program Overview
Alport syndrome, also known as hereditary nephritis, is a rare genetic disorder characterized by progressive kidney disease and abnormalities of the inner ear and the eye, affecting 30,000 to 60,000 patients in the US alone accountin... |
|
|
Updates in Mantle Cell Lymphoma
Discover insights on predictive and prognostic markers, emerging efficacy and safety data, strategies to optimize tolerability for patients receiving novel therapies for mantle cell lymphoma (MCL), and more in this case-based activity presented by John Leonard, MD, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology at Weill Cornell Medicine. Start the activity now.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is an aggressive variant of B-cell non-Hodgkin ly... |
|
|
Treatment Advances in Waldenstrom Macroglobulinemia
In this case-based discussion, Morie Gertz, MD, Chair of General Internal Medicine at the Mayo Clinic in Minnesota, will discuss how to use predictive and prognostic markers to select treatment for patients with Waldenstrom macroglobulinemia (WM) and how to appraise emerging clinical trial data and adverse event management strategies for novel treatments. Start the activity now.
STATEMENT OF NEED
Waldenstrom macroglobulinemia (WM) is a rare cancer of B lymphocytes associated with lymphop... |
|
|
ONC® Exam Review (Live Webinar) - Minneapolis
The ONC® Exam contains questions related to orthopedic patient-centered care nursing standards. By a comprehensive review of these standards, the participant will have the tools and knowledge necessary for successful preparation for orthopedic nursing certification. Content will include assessment and care for orthopedic patients experiencing pediatric/congenital/neuromuscular disorders, metabolic conditions, degenerative/inflammatory disorders, total joint arthroplasty, orthopedic trauma/con... |
|
|
Expert Consult Series in Multiple Sclerosis"Updates, Clinical Scenarios, and Future Directions - Activity 3: Which S1P receptor modulator is right for your patient?
Multiple sclerosis (MS) is a chronic immune-modulated inflammatory and neurodegenerative disease of the central nervous system. Advances in understanding have led to the development and approval of multiple disease-modifying therapies (DMTs) that offer established safety and efficacy profiles, a variety of mechanisms of action, and different routes of administration to better match an individual patient’s clinical needs, preferences, and tolerance for risk. Issues that have come to the foref... |
|
|
Inpatient Obstetric Nursing Exam Review (Live Webinar) - Minneapolis
Course Description
Presented in lecture format, this course reviews topics for the National Certification Corporation (NCC) Inpatient Obstetric Nursing Exam. Elements of the exam will be discussed, followed by a review of the content. The major components include disease processes during pregnancy, fetal evaluation, application of fetal monitoring for the laboring client and postpartum and neonatal assessments. Practice questions will enable the participant to increase confidence and experien... |
|
|
Ace the Case: Disease Progression in a 72-Year-Old Woman With Chronic Lymphocytic Leukemia Previously Treated With Venetoclax-Obinutuzumab
This activity utilizes a case study to discuss treatment options for an older patient with relapsed chronic lymphocytic leukemia (CLL). |
|
|
Neonatal Intensive Care Nursing Exam Review (Live Webinar) - Boston, MA
Course Description
This course is designed to supplement study materials for the NCC certification exam to obtain the RNC-NIC designation and the AACN certification exam to obtain the CCRN-neonatal designation. The course will focus on core concepts that are essential for caring for high-risk newborns. Preparation is recommended prior to participation in this course.
Program Learning Outcomes
This program prepares the learner to:
1. Review the core components covered by the exam throug... |
|
|
Neonatal Intensive Care Nursing Exam Review (Live Webinar) - Chicagoland
This course is designed to supplement study materials for the NCC certification exam to obtain the RNC-NIC designation and the AACN certification exam to obtain the CCRN-neonatal designation. The course will focus on core concepts that are essential for caring for high-risk newborns. Preparation is recommended prior to participation in this course.
PROGRAM LEARNING OUTCOMES
This program prepares the learner to:
1. Review the core components covered by the exam through test questions and... |
|
|
Ace the Case: 79-Year-Old Man With Lower Back Pain, Increasing Fatigue, and Right Rib Pain
This activity utilizes a case study to discuss treatment options for transplant-ineligible multiple myeloma (MM) patients. |
|
|
Advances in Osteoporosis: Emerging Approaches to Manage Male Patients
Activity Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of osteoporosis in men, with a forward-looking perspective on how the use of new and novel agents in men might impact clinical practice. An overview of male osteoporosis, as well as current and emerging treatment strategies, will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-ba... |
|
|
10-Night Great Barrier Reef CME AWAY® Cruise - Diabetes, Mood and Sleep Disorders, Osteoporosis, Thyroid Disease & Pain Management
Sydney, Australia • Eden, Australia • Airlie Beach, Qld, Australia • Cairns (Yorkey's Knob), Australia • Port Douglas, Australia • Willis Island (Cruising), Australia |
|
|
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment PODCAST 4:MS DMTs and vaccines
Program Overview
This podcast reviews considerations for starting disease-modifying therapy for a patient recently diagnosed with relapsing MS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Examine relevant data for choosing an appropriate DMT based on patient-specific characteristics
Incorporate evidence-based benefit-risk assessment and utilize shared decision making in the development of individualized treatment plans |
|
|
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment PODCAST 1: Newly Diagnosed Relapsing MS and Treatment Considerations
Program Overview
This podcast reviews considerations for starting disease-modifying therapy for a patient recently diagnosed with relapsing MS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Examine relevant data for choosing an appropriate DMT based on patient-specific characteristics
Incorporate evidence-based benefit-risk assessment and utilize shared decision making in the development of individualized treatment plans |
|
|
A Comprehensive Review of Metastatic Colorectal Cancer (mCRC) Management: An Interprofessional Approach to Care
TARGET AUDIENCE:
This activity is designed to meet the educational needs of oncologists, oncology nurses and pharmacists engaged in the care of patients with metastatic colorectal cancer.
PROGRAM OVERVIEW:
This interprofessional activity will cover:
• Changes in treatment combinations and sequencing of regimens, as well as molecular markers that should be tested to guide therapy.
• Supportive care measures and continual monitoring based on their therapy to ensure optimal outcomes an... |
|
|
Individualizing Treatment for Patients With Moderate-to-Severe Asthma: Strategies to Improve Care and Outcomes in Rural and Underserved Communities
Target Audience
This activity is designed specifically for primary care clinicians, registered nurses, and advanced practice registered nurses who care for patients from rural and underserved areas.
Program Overview
Asthma is a common, chronic respiratory disease that occurs in individuals of all ages. While asthma has a significant impact across the US, the condition places a disproportionate burden on individuals in rural and underserved communities. Rural areas struggle with delaye... |
|
|
Multidisciplinary Viewpoints on NTM-LD Diagnosis and Management
In two virtual roundtables, a pulmonologist, infectious disease specialist, and clinical pharmacist share their experiences in addressing challenges in diagnosing and treating patients with NTM-LD. The expert panel discusses strategies for expediting diagnosis and improving patient care and outcomes within the context of a patient’s reflections on the path to diagnosis and their treatment experience. Through this approach, learners hear from a real-world patient as the multidisciplinary pane... |
|
|
Raising Awareness of Uterine Fibroids: A Patient-Centered Approach to Optimize Outcomes in Rural and Underserved Settings
Target Audience
This activity is designed specifically for primary care clinicians, registered nurses, and advanced practice registered nurses who care for patients from rural and underserved areas.
Program Overview
Uterine fibroids are common, non-malignant tumors of the uterus that occur in up to 70% of women of reproductive age. While most cases are asymptomatic, approximately 25% of impacted individuals experience clinical symptoms that are severe enough to require treatment and n... |
|
|
Hiding in Plain Sight? A Focus on Diagnosing and Addressing the Unmet Needs in Homozygous Familial Hypercholesterolemia (HoFH)
TARGET AUDIENCE:
This educational activity has been designed to meet the needs of cardiology physicians, nurse practitioners, physician assistants, nurses, and other healthcare professionals interested in the diagnosis and management of HoFH.
PROGRAM OVERVIEW:
HoFH is a genetic disorder of lipid metabolism causing severely elevated low-density lipoprotein cholesterol (LDL-C) concentrations that lead to early onset atherosclerotic cardiovascular disease (ASCVD) and increased cardiovascular e... |
|
|
Recognition and Treatment of Hyperkalemia in Cardiometabolic Disease: Improving Care and Overcoming Challenges in Rural and Underserved Communities
TARGET AUDIENCE
This activity is designed specifically for primary care clinicians, registered nurses, and advanced practice registered nurses who care for patients from rural and underserved areas.
PROGRAM OVERVIEW
Hyperkalemia is a common electrolyte disorder associated with life-threatening cardiac arrhythmias and sudden death. In patients who have heart failure, chronic kidney disease, or diabetes mellitus or who use renin-angiotensin-aldosterone system inhibitors (RAASi), there is a pa... |
|
|
ForuMS: Highlights from the 2021 CMSC Annual Meeting
TARGET AUDIENCE:
This activity is designed to meet the educational needs of neurologists, primary care physicians, nurse practitioners, nurses, PAs, rehabilitation specialists, mental health specialists, radiologists, and other clinicians who are part of the team that manages patients with MS.
PROGRAM OVERVIEW:
This timely enduring activity is designed to review highlights from the 2021 CMSC annual meeting.
LEARNING OBJECTIVES:
Upon completion of this activity, participants should ... |
|
|
Expert Illustrations & Commentaries™: Harnessing the Power of SYK Inhibition to Reduce the Inflammatory Response in Patients Hospitalized With COVID
Target Audience
This educational activity is directed toward pulmonologists, infectious disease specialists, critical care clinicians, emergency medicine clinicians, internists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with COVID-19–induced acute respiratory distress syndrome (ARDS).
Program Overview
This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts discuss the etiolo... |
|
|
Expert Illustrations & Commentaries™: Harnessing the Power of SYK Inhibition to Reduce the Inflammatory Response in Patients Hospitalized With COVID
Target Audience
This educational activity is directed toward pulmonologists, infectious disease specialists, critical care clinicians, emergency medicine clinicians, internists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with COVID-19–induced acute respiratory distress syndrome (ARDS).
Program Overview
This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts discuss the etiolo... |
|
|
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment - PODCAST 2: MS Symptom Management
Target Audience
This activity is designed to meet the educational needs of neurologists, advanced practice clinicians, nurses, pharmacists, and other members of the healthcare team caring for patients with MS.
Program Overview
This podcast dicusses strategies for managing some of the symptoms experienced by people living with MS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Incorporate evidence-based benefit-risk assessment and ... |
|
|
Right Treatment, Right Time: Case-Based Podcasts on MS Treatment PODCAST 3:Suboptimal Response to Treatment/Breakthrough Disease
Target Audience
This activity is designed to meet the educational needs of neurologists, advanced practice clinicians, nurses, pharmacists, and other members of the healthcare team caring for patients with MS.
Program Overview
This podcast dicusses the evaluation and management of breakthrough disease activity.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Examine relevant data for choosing an appropriate DMT based on patient-spe... |
|